US2021228662A1PendingUtilityA1

Plant stem cell product treatments

Assignee: RAHIMI MARYAMPriority: Dec 6, 2018Filed: Apr 1, 2021Published: Jul 29, 2021
Est. expiryDec 6, 2038(~12.3 yrs left)· nominal 20-yr term from priority
A61K 36/73A61K 9/5036A61P 1/02A61M 15/06A01H 6/7418A61K 36/898A61K 9/0056A61K 9/006A61K 9/1647A61K 9/1273A61K 36/45A61P 35/00A61K 9/5026A61M 11/04C12N 5/04A61P 11/00A61C 15/046A61K 9/0073A61K 9/1652A61K 36/18
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the invention include plant stem cell products and treatment devices for applying the plant stem cell products. In some embodiments, the products include extracts of plant stem cells, such as lingonberry stem cells and orchid stem cells, and an aerosolizing device configured to create an aerosol from the plant stem cell products and to deliver the aerosol to the lung via inhalation.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A system for treating a lung condition, the system comprising:
 a plant stem cell product, comprising a lingonberry stem cell product or an orchid stem cell product; and   an aerosolizing device configured to create an aerosol from the plant stem cell product and to deliver the aerosol to the lungs via inhalation.   
     
     
         2 . The system of  claim 1 , wherein the lingonberry stem cell product includes one or more of a lingonberry stem cell extract, a lyophilized lingonberry stem cell, a lingonberry stem cell enriched medium, or an intact lingonberry stem cell. 
     
     
         3 . The system of  claim 2 , wherein the lingonberry stem cell is derived from a dedifferentiated cell of a lingonberry plant. 
     
     
         4 . The system of  claim 3 , wherein the dedifferentiated cell is derived from a stem, a meristem, a leaf, a flower, a fruit, a seed, a root, a root cap, an embryo, an explant, or a callus of the lingonberry plant. 
     
     
         5 . The system of  claim 1 , wherein the orchid stem cell product includes one or more of an orchid stem cell extract, a lyophilized orchid stem cell, an orchid stem cell enriched medium, or an intact orchid stem cell. 
     
     
         6 . The system of  claim 5 , wherein the orchid stem cell is derived from a dedifferentiated cell of an orchid plant. 
     
     
         7 . The system of  claim 6 , wherein the dedifferentiated cell is derived from a stem, a meristem, a leaf, a flower, a fruit, a seed, a root, a root cap, an embryo, an explant, or a callus of the orchid plant. 
     
     
         8 . The system of  claim 1 , wherein the plant stem cell product is encapsulated. 
     
     
         9 . The system of  claim 8 , wherein the plant stem cell product comprises an extract prepared by encapsulating a lysate of a cultured plant stem cell in a liposome. 
     
     
         10 . The system of  claim 9 , further comprising an excipient. 
     
     
         11 . The system of  claim 10 , wherein the excipient includes lactose, mannose, sodium chloride, a phospholipid, a poly lactic acid, a poly(lactic-co-glycolic acid), glycerol, a glycol, a surfactant, or a xanthan gum. 
     
     
         12 . The system of  claim 9 , wherein the plant stem cell product is a lingonberry stem cell extract including glycerin, gluconolactone, and xanthan gum. 
     
     
         13 . The system of  claim 9 , wherein the plant stem cell product is an orchid stem cell extract including glycerin, gluconolactone, and xanthan gum. 
     
     
         14 . The system of  claim 1 , wherein the aerosolizing device is a nebulizer, pressurized metered-dose inhaler, a personal vaporizer, a humidifier, a powder inhaler, a personal diffuser, a traditional cigarette, or an electronic-cigarette. 
     
     
         15 . A system for treating a lung condition, the system comprising:
 a plant stem cell product, comprising a plant stem cell other than ginseng, yew, or chrysanthemum, the plant stem cell encapsulated in a liposome comprising a phospholipid, glycerin, and xanthan gum; and   an aerosolizing device configured to create an aerosol from the plant stem cell product and to deliver the aerosol to the lungs via inhalation.   
     
     
         16 . The system of  claim 15 , wherein the plant stem cell product comprises an apple stem cell product, a lingonberry stem cell product, or an orchid stem cell product. 
     
     
         17 . The system of  claim 15 , wherein the aerosolizing device is a nebulizer, pressurized metered-dose inhaler, a personal vaporizer, a humidifier, a powder inhaler, a personal diffuser, a traditional cigarette, or an electronic-cigarette.

Join the waitlist — get patent alerts

Track US2021228662A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.